These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections]. Luczyński W, Stasiak-Barmuta A, Krawczuk-Rybak M, Zak J. Wiad Lek; 2004; 57(7-8):337-42. PubMed ID: 15631188 [Abstract] [Full Text] [Related]
5. [Intravenous immunoglobulin preparations in the adjuvant treatment of acute lymphoblastic leukemia in children]. Rokicka-Milewska R, Derulska D, Skwarska E. Pol Tyg Lek; 1988 Aug 22; 43(34):1085-7. PubMed ID: 3150782 [No Abstract] [Full Text] [Related]
6. [Effect of prognostic factors on the course of acute lymphoblastic leukemia in children]. Rokicka-Milewska R, Derulska D, Lewicki Z. Pediatr Pol; 1988 Nov 22; 63(11):703-15. PubMed ID: 3253657 [No Abstract] [Full Text] [Related]
7. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G. Haematologica; 1998 Sep 22; 83(9):791-9. PubMed ID: 9825576 [Abstract] [Full Text] [Related]
8. Acute lymphoblastic leukemia: dental health of children in maintenance therapy. Sepet E, Aytepe Z, Ozerkan AG, Yalman N, Guven Y, Anak S, Devecioglu O, Agaoglu L, Gedikoglu G. J Clin Pediatr Dent; 1998 Sep 22; 22(3):257-60. PubMed ID: 9641104 [Abstract] [Full Text] [Related]
9. [Second cessation of therapy in children with acute lymphoblastic leukemia]. Rokicka-Milewska R, Derulska D, Jackowska T, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Cyklis R, Duczmal B, Jakowicka M. Acta Haematol Pol; 1992 Sep 22; 23(1):43-7. PubMed ID: 1615750 [Abstract] [Full Text] [Related]
11. Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation. Sakamaki H, Yuasa K, Goto H, Tanikawa S, Akiyama H, Onozawa Y, Okamoto R, Maeda Y, Sasaki T, Kaku H, Tsuzuki S, Takamoto S, Mochida Y, Minematsu T, Minamishima Y. Bone Marrow Transplant; 1997 Jul 22; 20(2):143-7. PubMed ID: 9244418 [Abstract] [Full Text] [Related]
12. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991. Mauger DC, Skeen JE. N Z Med J; 1998 Nov 27; 111(1078):454-6. PubMed ID: 9891565 [Abstract] [Full Text] [Related]
13. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia. Sandoval C, Jayabose S. Pediatr Hematol Oncol; 2001 Nov 27; 18(3):217-20. PubMed ID: 11293291 [Abstract] [Full Text] [Related]
14. [Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol]. Bancillon A. Arch Fr Pediatr; 1991 Oct 27; 48(8):593-4. PubMed ID: 1768205 [No Abstract] [Full Text] [Related]
15. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method]. Ochocka M, Zelenay E. Pediatr Pol; 1988 Nov 27; 63(11):716-22. PubMed ID: 3253658 [No Abstract] [Full Text] [Related]
16. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)? Jakab Z, Balogh E, Karászi E, Kappelmayer J, Kiss C, Oláh E. Med Pediatr Oncol; 2002 Jul 27; 39(1):63-5. PubMed ID: 12116086 [No Abstract] [Full Text] [Related]
17. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study. Heath JA, Steinherz PG, Altman A, Sather H, Jhanwar S, Halpern S, Pieters R, Shah N, Steinherz L, Tannous R, Terry W, Trigg ME, Children's Cancer Group. J Clin Oncol; 2003 Apr 15; 21(8):1612-7. PubMed ID: 12697887 [Abstract] [Full Text] [Related]
18. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan. Matsuzaki A, Ishii E, Okamura J, Eguchi H, Yoshida N, Yanai F, Inoue T, Miyake K, Ishihara T, Tsuboi C. Med Pediatr Oncol; 1996 Jan 15; 26(1):10-9. PubMed ID: 7494507 [Abstract] [Full Text] [Related]
19. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96. Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ. J Clin Oncol; 2008 Apr 10; 26(11):1843-9. PubMed ID: 18398150 [Abstract] [Full Text] [Related]
20. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group. Eur J Haematol; 2007 Feb 10; 78(2):102-10. PubMed ID: 17087744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]